Privo is conducting a Phase 2 study evaluating the safety and efficacy of PRV111 in patients with T1-T2 oral cavity cancers.

For information regarding this trial, please visit https://clinicaltrials.gov/ct2/show/NCT03502148.

Contact Us

If you have any questions, please contact us by filling up the following form

Participating Hospitals

UT Health, University of Texas Science Center, Houston, TX 77030
Houston Methodist Hospital, 6550 Fannin Street, Suite 1701, Houston, TX 77030
Harris Health System – Smith Clinic, 2525A Holly Hall Street, Houston, TX 77054
Memorial Hermann-Texas Medical Center, Houston, TX 77030
Advanced ENT and Allergy, 2944 Breckenridge Lane
Louisville, KY 40220

Contact Us